Rapid differentiation of VLA1553 and wild-type ECSA chikungunya strains in the context of an IXCHIQ vaccination campaign

In 2024–2025, Réunion Island experienced a large outbreak driven by East-Central-South African (ECSA)-2 lineage of chikungunya virus (CHIKV), leading to the implementation of a vaccination campaign using live-attenuated IXCHIQ (VLA1553). Currently, distinguishing vaccine-derived viremia from wild-ty...

Descrición completa

Detalles Bibliográficos

Principais autores:	Laura Pezzi, Etienne Frumence, Konrad Wesselmann, Gregory Mollé, Lucie Falgous, Nazli Ayhan, Raphaelle Klitting, Guillaume André Durand, Gilda Grard, Emilie Mosnier, Patrick Gérardin, Antoine Nougairède, Remi Charrel, Marie-Christine Jaffar-Bandjee, Xavier de Lamballerie
Formato:	Artigo
Idioma:	Inglês
Publicado:	Taylor & Francis Group 2026-12-01
Series:	Emerging Microbes and Infections
Assuntos:	Chikungunya virus Arbovirus Vaccine IXCHIQ RT-qPCR VLA1553
Acceso en liña:	https://www.tandfonline.com/doi/10.1080/22221751.2026.2674363
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!